SDI Shares Suspended as Scheme Implementation Set for July 6
SDI Limited’s acquisition by Beijing Guoci subsidiary is now effective following New South Wales Supreme Court approval, with the ASX suspension commencing and cash payout scheduled for early July.
- Scheme of arrangement approved and effective
- SDI shares suspended from ASX trading
- Cash consideration of A$1.40 per share
- Implementation date set for 6 July 2026
- Acquirer backed by China’s Sinocera group
Court Approval Finalises SDI Acquisition Scheme
SDI Limited (ASX:SDI) has reached a pivotal milestone as its proposed acquisition by InnoXvest Dental, a subsidiary of Beijing Guoci Kebo Technology, became effective following the Supreme Court of New South Wales' approval. The court’s endorsement clears the legal hurdle for the scheme of arrangement under which SDI shareholders will receive A$1.40 in cash for each share they hold.
The scheme consideration price reflects a premium that was previously noted during shareholder discussions and regulatory approvals, underscoring the value Beijing Guoci and its parent, Shandong Sinocera Functional Material, place on SDI’s position in the dental materials market.
ASX Suspension and Implementation Timeline
Trading in SDI shares on the ASX was suspended from the close of trading on 25 June 2026, signalling the transition from a publicly traded company to a privately held entity under new ownership. The official implementation date for the scheme is set for 6 July 2026, when eligible shareholders recorded at 7:00pm Sydney time on 29 June will receive the cash payout.
This timeline marks the final administrative steps before Beijing Guoci assumes full control of SDI, a company renowned for manufacturing specialist dental materials in Victoria and distributing globally. The orderly suspension and payout process aims to minimise market disruption while delivering certainty to shareholders.
Strategic Backing from Sinocera and Beijing Guoci
Behind the acquisition is Sinocera, a Shenzhen Stock Exchange-listed advanced materials company with a broad industrial footprint including healthcare. Beijing Guoci, as the holding company for Sinocera’s dental businesses, has orchestrated this acquisition to expand its global dental materials portfolio.
SDI’s expertise in restorative dental products and its reputation for innovation in minimal intervention dentistry align with Sinocera’s strategic ambitions. The acquisition offers Beijing Guoci a foothold in the Australian manufacturing sector and access to SDI’s distribution network across more than 100 countries.
Next Steps and Shareholder Considerations
Shareholders should note that all dates related to the scheme’s implementation remain indicative and subject to change, with any updates to be communicated via ASX announcements. The orderly completion of the scheme will see SDI delisted from the ASX, ending its public company chapter after more than four decades.
Advisers Houlihan Lokey and DLA Piper continue to support SDI through this transition, ensuring compliance and smooth execution. For shareholders, the focus now shifts to receipt of the cash consideration and understanding the implications of the ownership change on SDI’s future operations.
Bottom Line?
The scheme’s effectiveness marks a clear turning point for SDI, transitioning it into private hands with a defined cash exit for shareholders and setting the stage for integration under Sinocera’s expanding dental materials empire.
Questions in the middle?
- How will Beijing Guoci integrate SDI’s operations within its global dental portfolio?
- What impact will the acquisition have on SDI’s ongoing R&D and innovation efforts?
- Could the scheme price of A$1.40 per share influence future M&A activity in the dental materials sector?
